RNA Outsourcing Resources

1. Advanced Therapies Going Mainstream: Are We There Yet? 11/14/2025

   Advanced therapies are nearing mainstream adoption, with cell, mRNA, and oligonucleotide treatments expanding into broader indications. Learn what’s driving this shift and what manufacturers must do.

2. Building Local Biomanufacturing Capacity In South Africa 2/11/2025

   Biovac evolved from a vaccine supplier to a biopharmaceutical innovator, providing a blueprint for expanding Africa's vaccine manufacturing capacity. Gain valuable insights from their journey.

3. Writing Effective Clinical Regulatory Documents For Therapy Trials 7/11/2025

   Clinical medical writing for gene therapy regulatory documents is a demanding, detail-oriented task that diverges significantly from medical writing for more traditional therapies.

4. Mastering mRNA Manufacturing: A Focus on Raw Materials & Supply Assurance 10/23/2024

   Rapid advancements in mRNA-based therapeutic development have underscored the role of raw material quality and supply chain management in ensuring their successful production.

5. Laminar And Turbulent Mixing Techniques For LNP Formulations Scale Up 11/4/2025

   Explore the critical factors in scaling up lipid nanoparticle (LNP) formulation, comparing the advantages and limitations of both laminar (microfluidic) and turbulent (tee and jet) mixing technologies.

6. Five Questions Biotechs Should Ask Before Selecting A Bioanalytical CRO 9/2/2025

   In a landscape where speed, quality, and trust are inseparable, choosing a CRO that shares your ambition is not optional; it is essential to survival and success.

7. Moving CGTx Clinical Development Forward In 2023 6/27/2023

   Gain insights on cell and gene therapy (CGTx) clinical trial design and commercialization strategies as a panel of industry experts share their considerations.

8. Outsourcing RNA-LNP Production: A Key To Competitive Success 3/6/2025

   Manufacturing RNA-containing LNPs demands specialized expertise. Explore some of the challenges of RNA-LNP drug manufacturing and the advantages of outsourcing RNA-LNP formulations.

9. Accelerated Development: Gene Therapy Vs. Small Molecule 12/26/2023

   Combined with the inherent difficulty of the chemistry behind gene therapy development, its pace, structure, and funding dynamics are unique among treatment modalities.

10. Transcribing RNA With Higher Purity, Activity While Using Less Cap Analog 2/11/2025

    Enhance RNA manufacturing with HiCap T7 RNA Polymerase, which minimizes dsRNA, boosts expression, and reduces capping costs for superior therapeutic development.